Rxivist logo

The emergence of a SARS-CoV-2 variant with a point mutation in the spike (S) protein, D614G, has taken precedence over the original Wuhan isolate by May 2020. With an increased infection and transmission rate, it is imperative to determine whether antibodies induced against the D614 isolate may cross-neutralize against the G614 variant. In this report, profiling of the anti-SARS-CoV-2 humoral immunity reveals similar neutralization profiles against both S protein variants, albeit waning neutralizing antibody capacity at the later phase of infection. These findings provide further insights towards the validity of current immune-based interventions.

Download data

  • Downloaded 281 times
  • Download rankings, all-time:
    • Site-wide: 66,263 out of 104,020
    • In immunology: 1,945 out of 3,257
  • Year to date:
    • Site-wide: 20,279 out of 104,020
  • Since beginning of last month:
    • Site-wide: 1,126 out of 104,020

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide


Sign up for the Rxivist weekly newsletter! (Click here for more details.)